
Public Joint Stock Company Magnit
Public Joint Stock Company Magnit is a Russian food and near-food retailer headquartered at 15/5 Solnechnaya Street, Krasnodar, 350072, Russia, founded in 1994 and listed on the Moscow Exchange under ticker MGNT. Magnit operates a multi-format estate spanning Magnit Convenience, Magnit Cosmetic, Magnit Pharmacy and Dixy. For fiscal 2025 the group reported revenue of US$36.18 billion and a net loss of US$0.18 billion, down from US$0.52 billion of net income in 2024. Scale is significant: roughly 385,000 employees and a market capitalisation of US$2.15 billion as of 2026-10, with shares at 4438.88.
Strengths: Magnit's multi-format portfolio — Magnit Convenience, Magnit Cosmetic, Magnit Pharmacy and Dixy — lets the retailer serve grocery, beauty and pharmacy demand across a single national footprint, deepening basket and visit frequency. Scale reinforces this: roughly 385,000 employees support one of Russia's largest retail networks, and revenue climbed from US$20.8 billion in 2020 to US$36.18 billion in 2025, a 74% increase. An independent Moscow Exchange listing with Marathon Group as principal shareholder keeps Magnit tied to domestic capital markets.
Weaknesses: Profitability is the clearest soft spot: net income slid from US$0.74 billion in 2023 to US$0.52 billion in 2024 and turned into a US$0.18 billion loss in 2025, even as revenue grew, signalling margin pressure that top-line expansion has not offset. Valuation has compressed sharply, with market capitalisation down from US$7.75 billion in 2020 to US$2.15 billion as of 2026-10, and the gap between rising rouble revenue (1,553.14 to 3,509) and shrinking dollar figures exposes heavy currency translation sensitivity. Disclosure is also thin, with asset figures unavailable, limiting balance-sheet assessment.
Read MoreShow Less
Public Joint Stock Company Magnit is a Russian food and near-food retailer headquartered at 15/5 Solnechnaya Street, Krasnodar, 350072, Russia, founded in 1994 and listed on the Moscow Exchange under ticker MGNT. Magnit operates a multi-format estate spanning Magnit Convenience, Magnit Cosmetic, Magnit Pharmacy and Dixy. For fiscal 2025 the group reported revenue of US$36.18 billion and a net loss of US$0.18 billion, down from US$0.52 billion of net income in 2024. Scale is significant: roughly 385,000 employees and a market capitalisation of US$2.15 billion as of 2026-10, with shares at 4438.88.
Strengths: Magnit's multi-format portfolio — Magnit Convenience, Magnit Cosmetic, Magnit Pharmacy and Dixy — lets the retailer serve grocery, beauty and pharmacy demand across a single national footprint, deepening basket and visit frequency. Scale reinforces this: roughly 385,000 employees support one of Russia's largest retail networks, and revenue climbed from US$20.8 billion in 2020 to US$36.18 billion in 2025, a 74% increase. An independent Moscow Exchange listing with Marathon Group as principal shareholder keeps Magnit tied to domestic capital markets.
Weaknesses: Profitability is the clearest soft spot: net income slid from US$0.74 billion in 2023 to US$0.52 billion in 2024 and turned into a US$0.18 billion loss in 2025, even as revenue grew, signalling margin pressure that top-line expansion has not offset. Valuation has compressed sharply, with market capitalisation down from US$7.75 billion in 2020 to US$2.15 billion as of 2026-10, and the gap between rising rouble revenue (1,553.14 to 3,509) and shrinking dollar figures exposes heavy currency translation sensitivity. Disclosure is also thin, with asset figures unavailable, limiting balance-sheet assessment.
Listed market data
MGNT · MOEX · weeklyHistory →- Market cap
- $2.1 B
- Share price
- —
- 1Y change
- —
- Recent change
- —
- Since first close
- —
- Revenue (TTM)
- US$36.2 B (FY2025)
In the press
All coverage →3 latest headlines1- Magnit reports RUB 3.72 trillion trailing 12-month revenue amid elevated debt servicing costs in Russiastockanalysis.com2026-10-01
- Magnit market capitalization fluctuates on Moscow Exchange as Net Debt/EBITDA rises to 2.9xtradingeconomics.com2026-10-01
- Magnit releases FY2025 and H1 2026 operational and financial key figures with CAPEX reaching RUB 187 billionmagnit.com2026-08-01
• Founded in 1994 and headquartered at 15/5 Solnechnaya Street, Krasnodar, 350072, Russia.
• Listed on the Moscow Exchange under ticker MGNT.
• Marathon Group is the principal shareholder, and the company is independently listed on the Moscow Exchange.
Retail brands – portfolio
• Operates Magnit Convenience, Magnit Cosmetic, Magnit Pharmacy and Dixy.
• Website is https://www.magnit.com.
• Industry classification is Life & Services.
Scale – workforce and revenue
• Employed 385,000 people.
• 2025 revenue was US$36.18 billion.
• 2024 revenue was US$32.8 billion.
Financial snapshot – profit and valuation
• 2025 net income was -US$0.18 billion.
• 2024 net income was US$0.52 billion.
• Market cap was US$2.15 billion as of 2026-10.
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2025 | $36.2 B | −$180 M |
| 2024 | $32.8 B | $520 M |
| 2023 | $28.5 B | $740 M |
| 2022 | $31.9 B | $580 M |
| 2021 | $24.9 B | $700 M |
| 2020 | $20.8 B | — |
Annual results from company filings (SEC XBRL), converted to US dollars.
Quick Facts
Headquarters
15/5 Solnechnaya Street, Krasnodar, 350072, Russia
Founded
1994
Employees
385,000
Revenue
US$36.2 B (FY2025)
Market cap
$2.1 B
Listing
listed
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website
